Researchers have developed lipid nanoparticles (LNPs) that cross the blood-brain barrier (BBB) and precisely target brain cells, a major step toward treating neurological diseases like Alzheimer’s.

Penn Engineers have developed a Lipid Nanoparticle (LNP) that delivers mRNA theraputic to the placenta to treat pre-eclampsia ...

The team unveiled its programmable LNP delivery platform in October 2023 and has continued to demonstrate the power of AI/ML to more safely and effectively deliver RNA therapies to specific ...

Wells Fargo has downgraded Editas (EDIT) to equal weight, citing concerns about the potential positioning of reni-cel. Read ...

Join experts from Pfizer, AstraZeneca, Moderna, BioNTech and Beam Therapeutics, as they dive deep into mechanisms of toxicity, optimal delivery strategy, PEG-lipid alternatives and in vitro prediction ...

Engineers at the University of Pennsylvania made a critical breakthrough that is should help cure pregnancies threatened with ...

Penn Engineers have made a critical breakthrough that bridges a major healthy equity gap for pregnant people with ...